All terms in GO
| Label | Id | Description |
|---|---|---|
| RNA polymerase binding | GO_0070063 | [Interacting selectively and non-covalently with an RNA polymerase molecule or complex.] |
| proline-rich region binding | GO_0070064 | [Interacting selectively and non-covalently with a proline-rich region, i.e. a region that contains a high proportion of proline residues, in a protein.] |
| cellubrevin-VAMP4-syntaxin-16 complex | GO_0070065 | [A SNARE complex that contains cellubrevin (VAMP3), VAMP4, and syntaxin 16 (or orthologs thereof).] |
| cellubrevin-VAMP4-endobrevin-syntaxin-6 complex | GO_0070066 | [A SNARE complex that contains cellubrevin (VAMP3), VAMP4, endobrevin (VAMP8), and syntaxin 6 (or orthologs thereof).] |
| syntaxin-6-syntaxin-16-Vti1a complex | GO_0070067 | [A SNARE complex that contains syntaxin 6, syntaxin 16, and Vti1a (or orthologs thereof).] |
| VAMP4-syntaxin-6-syntaxin-16-Vti1a complex | GO_0070068 | [A SNARE complex that contains VAMP4, syntaxin 6, syntaxin 16, and Vti1a (or orthologs thereof).] |
| chromatin remodeling involved in meiosis I | GO_1905886 | [Any chromatin remodeling that is involved in meiosis I.] |
| autoinducer AI-2 transmembrane transport | GO_1905887 | [The process in which (2R,4S)-2-methyltetrahydrofuran-2,3,3,4-tetrol (autoinducer AI-2) is transported across a membrane. AI-2 is produced by prokaryotes and is believed to play a role in quorum sensing.] |
| negative regulation of triglyceride transport | GO_1905884 | [Any process that stops, prevents or reduces the frequency, rate or extent of triglyceride transport.] |
| regulation of triglyceride transport | GO_1905883 | [Any process that modulates the frequency, rate or extent of triglyceride transport.] |
| positive regulation of triglyceride transport | GO_1905885 | [Any process that activates or increases the frequency, rate or extent of triglyceride transport.] |
| negative regulation of cellular response to very-low-density lipoprotein particle stimulus | GO_1905888 | [Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.] |
| regulation of cellular response to very-low-density lipoprotein particle stimulus | GO_1905890 | [Any process that modulates the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.] |
| cellular response to very-low-density lipoprotein particle stimulus | GO_0090731 | [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a very-low-density lipoprotein particle stimulus.] |
| positive regulation of cellular response to very-low-density lipoprotein particle stimulus | GO_1905889 | [Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.] |
| positive regulation of cellular response to thapsigargin | GO_1905893 | [Any process that activates or increases the frequency, rate or extent of cellular response to thapsigargin.] |
| regulation of cellular response to thapsigargin | GO_1905891 | [Any process that modulates the frequency, rate or extent of cellular response to thapsigargin.] |
| cellular response to thapsigargin | GO_1904579 | [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thapsigargin stimulus.] |
| regulation of cellular response to tunicamycin | GO_1905894 | [Any process that modulates the frequency, rate or extent of cellular response to tunicamycin.] |
| cellular response to tunicamycin | GO_1904577 | [Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tunicamycin stimulus.] |